Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium

Table 2

Patient characteristics.

Age groups (years)		β-Blockers	Statins	ASS	ACE inhibitors	AT1 antagonists
≤59	9	9	7 (78)	6 (66)	6 (66)	1 (11)
60–69	21	21	14 (66)	12 (57)	11 (52)	2 (95)
70–79	24	24	19 (79)	14 (58)	18 (75)	2 (83)
≥80	6	6	4 (66)	4 (67)	5 (83)	0 (0)
Total	60	60	44 (73)	36 (60)	40 (67)	5 (83)

All patients received β-adrenoceptor blockers as required by our inclusion criteria. Percentage of patients receiving per row the other drugs are given in percentage in brackets in order to facilitate comparison.